Search Within

Jason Philip Holland

Refine Results
Formats
  1. Journal Article (24)
  2. Meeting Abstract (6)
Groups
  1. Radiochemistry and Imaging Sciences Service (25)
  2. Radiology, Department of (25)
  3. Molecular Pharmacology and Chemistry Program Faculty (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Center for Hematologic Malignancies (8)
  6. Molecular Imaging and Therapy Service (7)

More Groups

People
  1. Jason Lewis (25)
  2. Charles Sawyers (6)
  3. Vadim Divilov (6)
  4. Michael Evans (5)
  5. Alessandro Ruggiero (4)
  6. Samuel Rice (4)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (4)
  4. 2012 (2)
  5. 2011 (6)
  6. 2010 (9)

More Years

Publications
  1. Journal of Nuclear Medicine (8)
  2. Journal of Clinical Oncology (2)
  3. Journal of Labelled Compounds and Radiopharmaceuticals (2)
  4. Molecular Imaging (2)
  5. Nuclear Medicine and Biology (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (8)
  2. Royal Society of Chemistry (3)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Science Inc. (2)
  5. Sage Publications, Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (30)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging androgen receptor signaling in prostate cancer with PET
    Meeting Abstract

    Evans, M.; Ulmert, D.; Holland, J.; Doran, M.; Spratt, D.; Sawyers, C.; Lewis, J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and89Zr-trastuzumab PET
    Journal Article

    Janjigian, Y. Y.; Viola-Villegas, N.; Holland, J. P.; Divilov, V.; Carlin, S. D.; Gomes DaGama, E. M.; Chiosis, G.; Carbonetti, G.; de Stanchina, E.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Annotating oncogene status in castration-resistant prostate cancer with zirconium-89-labeled radiotracers
    Meeting Abstract

    Evans, M. J.; Holland, J. P.; Ulmert, D.; Lewis, J. S.; Sawyers, C. L.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Imaging tumor burden in the brain with 89Zr-transferrin
    Journal Article

    Evans, M. J.; Holland, J. P.; Rice, S. L.; Doran, M. G.; Cheal, S. M.; Campos, C.; Carlin, S. D.; Mellinghoff, I. K.; Sawyers, C. L.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Annotating MYC status with 89Zr-transferrin imaging
    Journal Article

    Holland, J. P.; Evans, M. J.; Rice, S. L.; Wongvipat, J.; Sawyers, C. L.; Lewis, J. S.
    Nature Medicine (2012)

    Fulltext@MSK | Save
  • Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
    Journal Article

    Ulmert, D.; Evans, M. J.; Holland, J. P.; Rice, S. L.; Wongvipat, J.; Pettersson, K.; Abrahamsson, P. A.; Scardino, P. T.; Larson, S. M.; Lilja, H.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Meeting Abstract

    Janjigian, Y. Y.; Villegas, N. T.; Holland, J. P.; Shah, M. A.; Divilov, V.; Kelsen, D. P.; Lewis, J. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Zr-89 labeled trastuzumab as an effective non-invasive diagnostic agent for delineating Her2/neu-positive gastric cancer
    Meeting Abstract

    Viola-Villegas, N.; Janjigian, Y. Y.; Holland, J. P.; Divilov, V.; Lewis, J. S.
    Journal of Labelled Compounds and Radiopharmaceuticals (2011)

    Fulltext@MSK | Save